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Gap Junction Beta 2 (GJB2) gene mutations are the leading causes of hereditary hearing impairment. 
This gene encodes various gap junction proteins such as connexin 26 (Cx26), which facilitate K+ homeostasis 
inside the cochlea in the inner ear. It is as well identified in non-syndromic deafness, which is not accom-
panied with other abnormalities in the body and contributes to 75% of the cases. The protein connexin 26 is 
composed of four transmembrane helices and two extracellular loops, in which each has three specific, highly 
preserved, cysteine residues held by intramolecular disulfide bridges. Moreover, 35delG and Cys169Tyr are 
the most common mutations of GJB2, where the former results in a shortened Cx26 protein due to the termi-
nation of coding sequence, and the latter leads to a destabilized protein structure as one of the three cysteine 
residuals that are affected. This short review gives further insights on how these two types of mutations lead 
to hearing loss.
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D eafness is a hearing impairment that can be as a result of both genetic and environ-mental factors, and it is estimated that ap-
proximately 1 out 1000 children in the United States 
only are affected by it with half of these cases are 
due to genetic factors [1]. Deafness comes in various 
levels (moderate to severe) and has different types 
such as syndromic (25%), in which deafness is as-
sociated with other abnormalities in the body like 
blindness for example, and non-syndromic (75%), in 
which deafness is not accompanied with such symp-
toms [2]. Most of the genetic factors that contribute 
to hearing loss are caused by various mutations in 
the gene GJB2, which is also known as Gap Junction 
Beta 2 and it is found in chromosome 13, and mainly 
expressed in inner ear and skin. This important gene 
encodes for many gap junction proteins such as con-
nexin 26, connexin 30, connexin 43, and so on [3].
Furthermore, they are a group of membrane 
proteins whose main function is to facilitate the 
movement of certain ions, molecules, or even mes-
sengers that cannot pass through the hydrophobic 
part of the plasma membrane [4]. Among the various 
types of connexin proteins, mutations in connexin 26 
(Cx26) was found to be most causing cases of deaf-
ness, especially for non-syndromic that are inherited 
by autosomal recessive nature, and which accounts 
for 70% of the cases [5]. Moreover, connexin 26 has 
an important function in the K+ homeostasis inside 
the cochlea in the inner ear, and which part of the 
hearing process [6]. In this short review, we are 
going to discuss further the role of GJB2 mutations 
and how it leads to hearing impairment.
The GJB2 gene, cx2, and 
the hearing process
The GJB2 gene was the first gene to be iden-
tified in non-syndromic hearing impairment, and 
this suggests its importance in the coding of con-
nexin 26. It is the main gap junction protein in regu-
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Fig. 1. A. The flow of K+ ions into the hair cells via Cx 26 gap junctions at seterosilcia tips. B. This generates 
deploarization, which opens Ca2+ channels. When calcium enters, neurotransmitters are realeased onto the 
afferent nerve [9]
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lating K+ homeostasis during the normal function 
of hearing process, and which its mutations are re-
sponsible for most deafness cases [7]. Moreover, gap 
junction beta 2 is found in the long arms of chromo-
some 13 in positions 11 and 12, and has a length of 
5.5 kilobases. This gene also has two exons, but only 
one of them, exon 2, codes for Cx26. The coding re-
gion has about 681 base pairs and the mRNA, which 
translates into connexin 26 protein having 226 ami-
no acids, has a length of 2.4 kilobases [8]. 
When sound waves are collected by the outer 
ear and move through the inner canal, they hit the 
eardrum which has three connected bones called os-
sicles, and their function is to conduct vibrations to 
a snail shell-like structure called cochlea, found in 
the inner ear [9, 10]. The organ of Corti, which found 
inside the cochlea, contains hair cells which sensors 
the vibrations accompanied by the movement a fluid 
called ‘Endolymph’ [11]. As it moves the tiny hairs 
back and forth causing the influx of potassium ions 
into them through connexin 26 gap junctions located 
on stereo cilia of the hair cells [11]. Afterwards, the 
influx of potassium ions inside the hair cells gene-
rates an electrical impulse by depolarization as il-
lustrated in Fig. 1, which is eventually sent to the 
auditory nerve and thus the brain interprets as sound 
[9, 10].
connexin 26 protein
Connexin 26 (Cx26) protein is known as a gap 
junction protein. It is encoded by a gene called GJB2 
gene. The mutation in GJB2 gene is the most com-
mon cause of congenital sensorineural hearing loss, 
which accounts for 10% of all childhood hearing 
loss and about 20% of genetically hearing loss [12]. 
These percentages show the huge effect of this ge-
7netic mutation in GJB2 gene. To find out how this 
mutation influences the protein structure, it is im-
portant to know its location and biological function. 
Six connexin proteins are assembled together to 
form a connexon, which is also known as connexin 
hemichannel [13]. Two connexons from different 
cells will form a pore of a gap junction between the 
cytoplasm of the adjacent cells. This channel is re-
sponsible for the flow of ions and signaling mole-
cules in a bidirectional flow [13].
Protein Cx26 is composed of four transmem-
brane helices (from TM1 to TM4), as well as two 
extracellular loops (E1 & E2), functioning as the do-
mains of this protein [14]. These play a huge role in 
the interhemichannel interactions of the connexons, 
where the E1 and E2 complex of one hemichannel 
would interact with the E1 and E2 complex of the 
other hemichannel, as shown in Fig. 2 [15]. There is 
also an intracellular loop, a cytoplasmic N-terminal 
helix and a cytoplasmic C-terminus [14].
The connexin protein is composed of six con-
served cysteine residues that would form three in-
tramolecular disulfide bridges between E1 and E2, 
which contributes to the stabilization of the extra-
cellular region structure [15]. Each extracellular do-
main of the connexin protein, which are the E1 and 
E2 have three specific cysteine residues which are 
highly preserved in all connexins [16]. They form 
the intramolecular disulfide bridges between the 
cysteine residues. The disulfide bonds of the residual 
cysteine are between 53 and 180, 60 and 174, and 
also between 64 and 169 [17]. Studies on other pro-
teins have shown that a substitution of cysteine resi-
dues would result in the destabilization of the protein 
Fig. 2. This figure shows a representation of connexons in different cells forming the gap junctions. A. Loca-
tion of Cx26 within the membrane. B. Six of the Cx26 proteins form a hexamer and thus a gap junction chan-
nel. C. The structure of Cx26 showing all extracellular and intracellular domains alongside with mutations 
labeled on affected locations in the structure [14]
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structure [16]. This clearly shows the importance of 
sulfide bonds in maintaining the stability of the pro-
tein structure (Fig. 3, D).
mutations in the GJB2 gene 
As mentioned earlier, 50% of hearing impair-
ment cases are caused by genetic factors and most 
of them are due to mutations in the GJB2 gene. Be-
cause GJB2 codes for the instructions of making the 
protein Cx26, any changes in its nucleotide sequence 
might either result in a change of amino acids or de-
leting some of them contributing to the translation 
of a connexin 26 with an abnormal structure [18]. 
This irregular structure of the protein, whether it is 
incomplete or lost an essential bond that connects 
it with other monomers, it will surely lead it to be 
a faulty protein as all of its structure components 
plays a key role in stabilizing it, and so making able 
to carry its normal function [18].
According to recent research, the most common 
connexin 26 mutation is 35delG, and it is a frame 
shift mutation that involves the deletion of Guanine 
base at position 35, causing in a shifting of the se-
quence, and thus resulting in TGA, a premature stop 
codon. Consequently, the coding sequence is termi-
nated resulting in a shortened Cx26 protein [18].
Another important mutation that is worth con-
sidering is Cys169Tyr. This is a missense mutation, 
which also is a point mutation where one nucleo-
tide change would lead to a codon that codes for a 
different amino acid [19]. Correspondingly, in the 
codon TGC that codes for the amino acid cysteine 
at position 167, in the protein sequence of 226 amino 
acids, the mutation involves the switch of nitroge-
Fig. 3. Illustrates the process of Cys169Tyr mutation. A. The normal sequence, B. demonstrates where the 
base guanine was switched to adenine, and C. The mutated sequence where tyrosine was coded instead of 
cysteine. D. Schematic representation of Cx26 normal structure. The three disulfide bonds are colored in red, 
and two cysteine amino acids 64 and 169 form one disulfide bond. E. Schematic representation of Cx26, where 
the CYS 169 residue is replaced with tyrosine. It results in the loss of a crucial disulfide bond, which contribute 
to the stabilization of the protein structure [17]
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9nous base Guanine to Adenine, which consequently 
lead to the translation of tyrosine instead of cysteine 
as presented in Fig. 3, A-C.
Although the translation of protein structure 
is completed, the resulting protein has an abnormal 
structure of the extracellular domain E2 [17].  This 
mutation occurs in a highly conserved region, which 
affects one of the three cysteine residues responsible 
for disulfide bonds, which are extremely important 
for the connexon-connexon interaction. These as 
well stabilize the three-dimensional structure be-
tween the extracellular domains E1 and E2 of the 
protein connexin 26 [19].
Cys169Tyr results in the destruction of a third 
disulfide bridge between cysteine residues 64 and 
169 in the protein complex as shown in Fig. 3, E 
[17]. This leads to the alteration of the three-dimen-
sional structure of the whole connexin 26 molecule 
[19]. Consequently, the inhibition of the interactions 
between connexons of neighboring cells would oc-
cur as well as proper anchoring of connexions in 
the membrane [20]. Accordingly, the interactions 
between the cells are affected due to the changes 
occurring in the connexin protein structures [19]. 
Therefore, the exchange of low-molecular substances 
can no longer occur, as well as the regulation of the 
potassium ions homeostasis. This will hinder other 
processes in the inner ear and would eventually re-
sult in hearing loss [19, 20].
future perspectives 
In order to treat this condition, conducting 
further research on using interference RNA and 
gene therapy is highly recommended.  According to 
scien tific literature, this was successfully attempted 
on transgenic mice and it has resulted in promising 
results [21]. Using small interference RNA mecha-
nism, the target mRNA, Cys169Tyr Gjb2 in this case 
is degraded in the cytoplasm after transcription and 
so down regulating the gene expression [22]. The vi-
ral packaging and delivery of miRNA to Gjb2 Cys-
169Tyr human embryos would result in long-term 
silencing of the Cys169Tyr genes. In addition, the 
best proposed vector is “bovine adeno associated 
virus’’, which is a single stranded DNA virus and 
has been shown to be very efficient in gene trans-
fer, as well as relatively safe for causing no cyto-
toxicity according to previous work done by resear-
chers [21]. The BAA viruses could be then injected 
to the human embryonic cells in the uterus through 
microinjec tions methods at suitable time (Before 
the cochlea develops). Finally, the expression of the 
genes can be assessed using western blots and the 
newborn hearing processes using ‘Auditory brain-
stem responses’ [21,22]. For this reason, advanced 
research on orphan diseases such as inherited deaf-
ness due to GJB2 mutations using gene therapy and 
other molecular techniques is highly encouraged.
In conclusion, the proper function of the con-
nexin 26 protein can be achieved thanks to the 
proper bonding of the three disulfide bridges at the 
cysteine residues 53 and 180, 60 and 174, in addition 
to 64 and 169. These cysteine residues are crucial 
in maintaining the stability of the protein structure. 
When the missense mutation in the GJB2 gene oc-
curs, the cysteine residue in position 169 is replaced 
by a tyrosine, resulting in the loss of one disulfide 
bridge that is binding two connexons. Since the 
binding happens between the domains E1 and E2 of 
the connexons, no gap junction would be formed, 
where the potassium ions can move and contribute to 
the hearing process. The loss of this crucial biologi-
cal function will result in deafness, which is a seri-
ous health problem that is affects many individuals, 
and can be treated using gene therapy in near future. 
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Мутації гена GJB2 (Gap Junction Beta 2) є 
однією з головних причин спадкового пору-
шення слуху. Цей ген кодує різні протеїни щі-
линних контактів, зокрема конексину 26 (Cx26), 
який сприяє гомеостазу K+ всередині равлика 
внутрішнього вуха. Мутації GJB2 також вияв-
лено у разі несиндромальної глухоти (75% ви-
падків), яка не супроводжується іншими анома-
ліями в організмі. Cx26 складається з чотирьох 
трансмембранних спіралей і двох позаклітин-
них петель, в кожній з яких є три специфічних, 
консервативних залишки цистеїну, зв’язаних 
внутрішньомолекулярними дисульфідними 
містками. Мутації 35delG і Cys169Tyr є найпоши-
ренішими мутаціями GJB2. Перша призводить 
до скорочення протеїну Cx26 через переривання 
послідовності, що кодує, а друга – до дестабі-
лізації структури протеїну через пошкодження 
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одного із трьох залишків цистеїну. В цьому ко-
роткому огляді надано додаткові дані про те, як 
ці два типи мутацій призводять до втрати слуху.
К л ю ч о в і  с л о в а: Gap Junction Beta 2 
(GJB2) ген, конексин 26 (Cx26), несиндромальна 
форма, 35delG, Cys169Tyr, спадкова туговухість. 
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Мутации гена GJB2 (Gap Junction Beta 2) 
являются одной из главных причин наслед-
ственного нарушения слуха. Этот ген кодирует 
различные протеины щелевых контактов, в част-
ности коннексин 26 (Cx26), способствующий 
гомеостазу K+ внутри улитки внутреннего уха. 
Мутации GJB2 также выявлены при несиндро-
мальной тугоухости (в 75% случаев), которая не 
сопровождается другими аномалиями в организ-
ме. Cx26 состоит из четырех трансмембранных 
спиралей и двух внеклеточных петель, в каждой 
из которых имеется три специфических, консер-
вативных остатка цистеина, связанных внутри-
молекулярными дисульфидными мостиками. 
Мутации 35delG и Cys169Tyr являются наиболее 
распространенными мутациями GJB2. Первая 
приводит к укороченному протеину Cx26 из-за 
прерывания кодирующей последовательности, а 
вторая – к дестабилизации его структуры из-за 
повреждения одного из трех остатков цис теина. 
В этом коротком обзоре представлены дополни-
тельные данные о том как эти два типа мутаций 
приводят к потере слуха.
К л ю ч е в ы е  с л о в а: Gap Junction Beta 2 
(GJB2) ген, коннексин 26 (Cx26), несиндромаль-
ная форма, 35delG, Cys169Tyr, наследственная 
тугоухость.
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